Kimberly Jewett Discusses Pathology as Part of the Treatment Process

Article

Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Kimberly Jewett, a two-time breast cancer survivor, president and CEO, Kimberly Jewett Consulting, Inc., discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman with shoulder-length black hair wearing headphones and a white sweater
Liquid Biopsies Are More Feasible, Appropriate for ESR1+ Breast Cancer
Image of a woman with a blue background
Practicing ‘Top of License’ Can Enhance Patient Care, Collaboration
5 experts in this video
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment Strategies
5 experts in this video
Emerging First-Line Clinical Trials in HER2+ mBC: Insights from HER2CLIMB05, INAVO122, and Other Trials Advancing Precision Medicine
Image of a man in scrubs with short hair and glasses
Redeployment Engages Oncology PA Skills, Reduces Burnout
Photo of a woman with brown hair and bangs, surrounded by a blue border
Evaluating Options for Second-Line HR+, HER2- Breast Cancer Treatment
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
Optimizing RCC Treatment: Integrating Patient-Reported Outcomes and Clinician Insights
Quality of Life and Treatment Experience: Patient-Reported Outcomes from TiNivo-2
Quality of Life and Treatment Experience: Patient-Reported Outcomes from TiNivo-2
TiNivo-2 Phase 3 Trial: Survival Data and Practical Approaches to Dose Management in Practice
TiNivo-2 Phase 3 Trial: Survival Data and Practical Approaches to Dose Management in Practice
Optimizing VEGFR-TKI Therapy: Perspectives on Patient Selection and Management Strategies in Clinic
Optimizing VEGFR-TKI Therapy: Perspectives on Patient Selection and Management Strategies in Clinic
Related Content
Oncology Nurses Provide Patients an Avenue to Supportive Care

Oncology Nurses Provide Patients an Avenue to Supportive Care

Diana Martins-Welch, MD
November 12th 2019
Article

Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

New Findings Could Change the Everyday Treatment of Patients With Advanced Prostate Cancer

Daniel J. George, MD
October 3rd 2019
Article

For patients with advanced prostate cancer, new findings from the CARD trial could change their daily treatment.

Adverse Events of CAR T-Cell Therapy

Adverse Events of CAR T-Cell Therapy

Sattva S. Neelapu, MD
July 28th 2019
Article

It is crucial for nurses to be aware of adverse events that can occur in patients who are receiving CAR T-cell therapy, explained one expert.

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

Prostate Cancer Diagnoses Decrease With Lenient Screening Recommendations

MaryBeth Freeman, MPH
May 8th 2019
Article

After the USPSTF advised against prostate cancer screening for all men, there was a decrease in the incidence of the disease.

Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer

Hyman B. Muss, MD
March 23rd 2016
Article

Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.

Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making

Kimberly J. Van Zee, MS, MD, FACS
March 18th 2016
Article

Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).